Based on the Type: Monovalent Vaccines, Multivalent Vaccines.
Based on Route of Administration: Intramuscular and Subcutaneous Administration, Oral Administration, and Other Routes of Administration
Based on Patient Type: Pediatrics, Adults, and Travelers.
Based on the Region: Latin America, Europe, North America, Asia Pacific, and the Middle East and Africa.
Key players in the market are Astellas Pharma Inc. (Japan), CSL Limited (Australia), GlaxoSmithKline plc (UK), Johnson & Johnson (US), Emergent BioSolutions, Inc. (US), MedImmune, LLC (US), Merck & Co., Inc. (US), Serum Institute of India Pvt. Ltd. (India), Pfizer, Inc. (US), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Biological E (India), Sanofi Pasteur (France), Panacea Biotec (India),and Daiichi Sankyo (Japan).
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.